Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HCAR Stock Summary
In the News
HCAR Financial details
Company Rating
Neutral
Market Cap
0
Income
18.54M
Revenue
0
Book val./share
-2.04
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Mar 2021
P/E
36.08
Forward P/E
-
PEG
-0.01
P/S
-
P/B
-24.71
P/C
1010
P/FCF
-
Quick Ratio
0.13
Current Ratio
0.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.61
EPS next Y
-
EPS next Q
-
EPS this Y
-109385.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-52.31%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
1.69%
Inst Trans
0.02%
ROA
3%
ROE
-59%
ROC
0.04%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.7099-10.11
52W High
+1%
52W Low
+12.22%
RSI
-
Rel Volume
0.05
Avg Volume
140.71K
Volume
6.55K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0.05%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
10.1
Change
0%
HCAR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2020-12-31 | 2021-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0 | 3.06 | |
Operating cash flow per share | 0 | -0.11 | |
Free cash flow per share | 0 | -0.11 | |
Cash per share | 8.02 | 0.09 | |
Book value per share | 7.75 | -3.31 | |
Tangible book value per share | 7.75 | 36.69 | |
Share holders equity per share | 7.75 | -3.31 | |
Interest debt per share | 0 | -1.78 | |
Market cap | 414M | 80.81M | |
Enterprise value | 413.08M | 80.07M | |
P/E ratio | -3.57K | 3.19 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | 0 | -88.95 | |
PFCF ratio | 0 | -88.95 | |
P/B Ratio | 1.29 | -2.95 | |
PTB ratio | 1.29 | -2.95 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -3.56K | 7.54 | |
EV to operating cash flow | 0 | -88.13 | |
EV to free cash flow | 0 | -88.13 | |
Earnings yield | 0 | 0.31 | |
Free cash flow yield | 0 | -0.01 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 7.96 | -0.07 | |
Current ratio | 7.93 | 4.19 | |
Interest coverage | 0 | 0.28 | |
Income quality | 0 | -0.09 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0.7 | 15.09 | |
ROIC | 0 | 0.36 | |
Return on tangible assets | 0 | 0.08 | |
Graham Net | 7.74 | -3.34 | |
Working capital | 1.22M | 743.82K | |
Tangible asset value | 320.82M | 303.82M | |
Net current asset value | -10.37M | -27.45M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 40.45K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | -0.93 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.14 | 0.21 | 0.44 | 0.65 | 0.31 | |
Operating cash flow per share | 0 | -0.01 | -0.05 | -0.03 | -0.02 | |
Free cash flow per share | 0 | -0.01 | -0.05 | -0.03 | -0.02 | |
Cash per share | 0.01 | 0.02 | 0.04 | 0.03 | 0.01 | |
Book value per share | -0.93 | -0.83 | -2.86 | -2.23 | -2.04 | |
Tangible book value per share | 9.07 | 9.17 | 37.14 | 37.79 | 38.09 | |
Share holders equity per share | -0.93 | -0.83 | -2.86 | -2.23 | -2.04 | |
Interest debt per share | 0 | -0.11 | 0 | 0 | 0 | |
Market cap | 322.92M | 323.25M | 81.14M | 81.48M | 82.22M | |
Enterprise value | 322.5M | 322.51M | 80.82M | 81.19M | 82.14M | |
P/E ratio | 17.08 | 11.62 | 5.52 | 3.78 | 8.13 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.08K | -1.1K | -184.12 | -331.55 | -398.74 | |
PFCF ratio | -2.08K | -1.1K | -184.12 | -331.55 | -398.74 | |
P/B Ratio | -10.49 | -11.8 | -3.42 | -4.41 | -4.86 | |
PTB ratio | -10.49 | -11.8 | -3.42 | -4.41 | -4.86 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 68.24 | 95.19 | 22 | 14.8 | 28.35 | |
EV to operating cash flow | -2.08K | -1.1K | -183.39 | -330.4 | -398.37 | |
EV to free cash flow | -2.08K | -1.1K | -183.39 | -330.4 | -398.37 | |
Earnings yield | 0.01 | 0.02 | 0.05 | 0.07 | 0.03 | |
Free cash flow yield | 0 | 0 | -0.01 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.09 | -0.22 | -0.09 | -0.05 | -0.03 | |
Current ratio | 2.69 | 4.19 | 2.83 | 2.23 | 0.3 | |
Interest coverage | 0 | 0.06 | 0 | 0 | 0 | |
Income quality | -0.03 | -0.09 | -0.12 | -0.05 | -0.08 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.73 | 1.98 | 5.35 | 5.72 | 3.75 | |
ROIC | 0.04 | 0.02 | -0.15 | -0.29 | -0.15 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Graham Net | -0.94 | -0.84 | -2.91 | -2.28 | -2.13 | |
Working capital | 453.9K | 743.82K | 394.7K | 262.04K | -408.29K | |
Tangible asset value | 300.43M | 303.82M | 307.49M | 312.88M | 315.4M | |
Net current asset value | -30.81M | -27.45M | -23.8M | -18.69M | -17.56M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 75.76K | 70.92K | 72.48K | 85.5K | 70.93K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.15 | -0.25 | -0.15 | -0.29 | -0.15 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HCAR Frequently Asked Questions
What is Healthcare Services Acquisition Corporation stock symbol ?
Healthcare Services Acquisition Corporation is a US stock , located in Bethesda of Md and trading under the symbol HCAR
What is Healthcare Services Acquisition Corporation stock quote today ?
Healthcare Services Acquisition Corporation stock price is $10.1 today.
Is Healthcare Services Acquisition Corporation stock public?
Yes, Healthcare Services Acquisition Corporation is a publicly traded company.